戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nd humoral immune responses were assessed by anticapsular and antiprotein IgG concentrations.Measurem
2    Adults respond to NP carriage by mounting anticapsular and weak antiprotein antibody responses, an
3 t limiting doses, the polysaccharide-induced anticapsular antibodies also were less effective in conf
4 rmination of the binding of Fab fragments of anticapsular antibodies as a measure of matrix density;
5 order to assess if it is feasible to develop anticapsular antibodies as a potential novel therapy, it
6 ticapsular antibodies, but not all sera with anticapsular antibodies conferred protection.
7         These results indicate that systemic anticapsular antibodies conferred significant protection
8 isparities in the functional activity of the anticapsular antibodies elicited in adults by the two va
9 uate the effect of passive immunization with anticapsular antibodies on nasopharyngeal carriage, two
10  but it is not known whether vaccine-induced anticapsular antibodies that lack bactericidal activity
11      In the present study, polyclonal rabbit anticapsular antibodies were cross-absorbed to produce s
12                  These results indicate that anticapsular antibodies with different epitope specifici
13 was associated with higher concentrations of anticapsular antibodies, but not all sera with anticapsu
14        Moreover, the quality and function of anticapsular antibodies, measured as avidity and in vitr
15 ty is associated with higher-avidity group C anticapsular antibodies, which are present in concentrat
16 ng been assumed to depend on the presence of anticapsular antibodies.
17 mine the protective capacity of pneumococcal anticapsular antibodies.
18                                              Anticapsular antibody at doses fivefold higher (0.18 to
19 activity had a higher geometric mean group C anticapsular antibody concentration (0.72 microg/ml) tha
20              Of 18 nonbactericidal sera with anticapsular antibody concentrations between 0.31 and 0.
21  were assayed for serogroups C, W-135, and Y anticapsular antibody concentrations by use of a radioan
22                                      Group C anticapsular antibody concentrations were measured by a
23 ccines elicit higher concentrations of serum anticapsular antibody in infants and children than do un
24 had no effect on bacteremia, whereas group C anticapsular antibody in sera from adults immunized with
25  of life, whereas maternal serotype-specific anticapsular antibody is associated with protection agai
26         Survival, organ fungus burden, serum anticapsular antibody levels, and histopathology by ligh
27 ity functions as an important determinant of anticapsular antibody protective efficacy against pneumo
28                                     Salivary anticapsular antibody responses to a 7-valent pneumococc
29 ncentrations of polysaccharide-induced serum anticapsular antibody to achieve 50% complement-mediated
30                        PHS plus a monoclonal anticapsular antibody, 3C2, had an additive effect on bi
31 ogous or homologous strain did not depend on anticapsular antibody.
32           This was observed with and without anticapsular antibody.
33 group had up to 7-fold-higher geometric mean anticapsular-antibody titers than the alum group and 5-
34 MF59 group still showed 5- to 10-fold-higher anticapsular-antibody titers.
35 apsular type by serological testing based on anticapsular antisera and by different WGS-based pipelin
36           For serotype 14, a higher level of anticapsular IgG at the beginning of the study was assoc
37 in antibody responses, and naturally induced anticapsular IgG can prevent carriage.
38                                    Levels of anticapsular IgG increased significantly after carriage
39 t (i) there are multiple mechanisms by which anticapsular IgG MAbs facilitate phagocytosis of encapsu
40 vidity and opsonophagocytic functions of the anticapsular IgG were similar.
41                        GBS serotype-specific anticapsular immunoglobulin G (IgG) was measured on mate
42               Vaccination with PCV13 induces anticapsular immunoglobulin G and opsonophagocytic antib
43 f an anti-GNA33 mAb is similar to that of an anticapsular mAb but less active than an anti-P1.2 mAb.
44          We previously reported developing 2 anticapsular monoclonal antibodies (mAbs) as a novel the
45 g fluorophore-labeled polyclonal anti-C3 and anticapsular monoclonal antibodies and rosetting of fluo
46 eutrophils in the presence of complement and anticapsular or anti-O antigen antiserum.
47 ise studies that have investigated GBS serum anticapsular or anti-protein antibodies, and studies mea
48 phagocytic assay (OPA) and compared with IgG anticapsular polysaccharide antibody concentrations meas
49                  Coating of pneumococci with anticapsular polysaccharide antibody unmasked the bacter
50 odies to dams demonstrated conclusively that anticapsular polysaccharide IgG alone is sufficient for
51                                 Increases in anticapsular polysaccharide immunoglobulin G concentrati
52                         The concentration of anticapsular PS antibodies strongly correlated (r = .72